Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Current Topics in Medicinal Chemistry
|
September 27, 2005
Synergistic approaches to clinical oncology biomarker discovery
Stanley M Belkowski, Deborah Polkovitch, Michael R D'Andrea
Trends in Biotechnology
|
July 31, 2004
Biomarker discovery and validation: technologies and integrative approaches
Sergey E Ilyin, Stanley M Belkowski, Carlos R Plata-Salamán
BMC Complementary and Alternative Medicine
|
June 15, 2007
Immunomodulation of murine collagen-induced arthritis by N, N-dimethylglycine and a preparation of Perna canaliculus
Brian R Lawson, Stanley M Belkowski, John F Whitesides, et al.
Biological Chemistry
|
August 21, 2008
Cleaved SLPI, a novel biomarker of chymase activity
Stanley M Belkowski, John Masucci, Andrew Mahan, et al.
Journal of Computational Biology : a Journal of Computational Molecular Cell Biology
|
June 15, 2007
A consolidated approach to analyzing data from high-throughput protein microarrays with an application to immune response profiling in humans
Mariusz Lubomirski, Michael R D'Andrea, Stanley M Belkowski, et al.
Bioorganic & Medicinal Chemistry
|
September 6, 2005
The synthesis and evaluation of 10- and 12-membered ring benzofused enediyne amino acids
Yanming Du, Christopher J Creighton, Zhengyin Yan, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 2, 2002
Early growth response transcription factors are required for development of CD4(-)CD8(-) thymocytes to the CD4(+)CD8(+) stage
Michael Carleton, Mariëlle C Haks, Sigrid A A Smeele, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 11, 2003
Low activation threshold as a mechanism for ligand-independent signaling in pre-T cells
Mariëlle C Haks, Stanley M Belkowski, Maria Ciofani, et al.
Methods (San Diego, Calif.)
|
November 26, 2005
Integrated expressional analysis: application to the drug discovery process
Sergey E Ilyin, Daniel Horowitz, Stanley M Belkowski, et al.
The Journal of Rheumatology
|
August 3, 2015
Results from a Phase IIA Parallel Group Study of JNJ-40346527, an Oral CSF-1R Inhibitor, in Patients with Active Rheumatoid Arthritis despite Disease-modifying Antirheumatic Drug Therapy
Mark C Genovese, Elizabeth Hsia, Stanley M Belkowski, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Current Topics in Medicinal Chemistry
|
September 27, 2005
Synergistic approaches to clinical oncology biomarker discovery
Stanley M Belkowski, Deborah Polkovitch, Michael R D'Andrea
Trends in Biotechnology
|
July 31, 2004
Biomarker discovery and validation: technologies and integrative approaches
Sergey E Ilyin, Stanley M Belkowski, Carlos R Plata-Salamán
BMC Complementary and Alternative Medicine
|
June 15, 2007
Immunomodulation of murine collagen-induced arthritis by N, N-dimethylglycine and a preparation of Perna canaliculus
Brian R Lawson, Stanley M Belkowski, John F Whitesides, et al.
Biological Chemistry
|
August 21, 2008
Cleaved SLPI, a novel biomarker of chymase activity
Stanley M Belkowski, John Masucci, Andrew Mahan, et al.
Journal of Computational Biology : a Journal of Computational Molecular Cell Biology
|
June 15, 2007
A consolidated approach to analyzing data from high-throughput protein microarrays with an application to immune response profiling in humans
Mariusz Lubomirski, Michael R D'Andrea, Stanley M Belkowski, et al.
Bioorganic & Medicinal Chemistry
|
September 6, 2005
The synthesis and evaluation of 10- and 12-membered ring benzofused enediyne amino acids
Yanming Du, Christopher J Creighton, Zhengyin Yan, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 2, 2002
Early growth response transcription factors are required for development of CD4(-)CD8(-) thymocytes to the CD4(+)CD8(+) stage
Michael Carleton, Mariëlle C Haks, Sigrid A A Smeele, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 11, 2003
Low activation threshold as a mechanism for ligand-independent signaling in pre-T cells
Mariëlle C Haks, Stanley M Belkowski, Maria Ciofani, et al.
Methods (San Diego, Calif.)
|
November 26, 2005
Integrated expressional analysis: application to the drug discovery process
Sergey E Ilyin, Daniel Horowitz, Stanley M Belkowski, et al.
The Journal of Rheumatology
|
August 3, 2015
Results from a Phase IIA Parallel Group Study of JNJ-40346527, an Oral CSF-1R Inhibitor, in Patients with Active Rheumatoid Arthritis despite Disease-modifying Antirheumatic Drug Therapy
Mark C Genovese, Elizabeth Hsia, Stanley M Belkowski, et al.
Page
of 2